3-fluoro-4-(trifluoromethyl)aniline
CAS: 69411-68-3
Ref. 3D-FF105008
1g | Discontinued | ||
2g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
25g | Discontinued |
Product Information
- 2-Ethenyl-1,1-Difluorocyclopropane
- 2-Fluoro-4-aminobenzotrifluoride
- 3-Fluoro-4-(trifluoromethyl)aniline
- 3-Fluoro-4-(trifluoromethyl)benzenamine
- 3-Fluoro-4-trifluoromethylphenylamine
- Benzenamine, 3-fluoro-4-(trifluoromethyl)-
- 4-Amino-2-fluorobenzotrifluoride
3-fluoro-4-(trifluoromethyl)aniline is a selective Pparδ agonist that has been shown to inhibit the replication cycle of HIV. It has been shown to stimulate transcriptional activity in myotubes and multiwell plates, which may be due to its ability to activate the transcription factor CREB. 3-fluoro-4-(trifluoromethyl)aniline has also been shown to have agonist activities on the arylpiperazine site of the purinergic receptors, and it can also induce focussing on triazoles. This drug is categorized as a CYP3A inhibitor due to its ability to inhibit cyclic adenosine monophosphate (cAMP) production.